A LOW BASELINE BLOOD NEUTROPHIL COUNT AND A HIGH PERCENTAGE OF TREG AMONG LEUCOCYTES ARE ASSOCIATED WITH AN INCREASED OVERALL SURVIVAL OF RECURRENT HIGH-GRADE GLIOMA PATIENTS TREATED WITH BEVACIZUMAB - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Neuro-Oncology Année : 2016

A LOW BASELINE BLOOD NEUTROPHIL COUNT AND A HIGH PERCENTAGE OF TREG AMONG LEUCOCYTES ARE ASSOCIATED WITH AN INCREASED OVERALL SURVIVAL OF RECURRENT HIGH-GRADE GLIOMA PATIENTS TREATED WITH BEVACIZUMAB

Résumé

Conference: 12th Meeting of the European-Association-of-Neuro-Oncology Location: GERMANY Date: OCT 12-16, 2016 - Meeting Abstract: P06.13

Domaines

Cancer

Dates et versions

hal-01416104 , version 1 (14-12-2016)

Identifiants

Citer

V. Quillien, A. Carpentier, A. Gey, T. Avril, E. Tartour, et al.. A LOW BASELINE BLOOD NEUTROPHIL COUNT AND A HIGH PERCENTAGE OF TREG AMONG LEUCOCYTES ARE ASSOCIATED WITH AN INCREASED OVERALL SURVIVAL OF RECURRENT HIGH-GRADE GLIOMA PATIENTS TREATED WITH BEVACIZUMAB. Neuro-Oncology, 2016, 18 (suppl_4), pp.30-31. ⟨10.1093/neuonc/now188.104⟩. ⟨hal-01416104⟩
32 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More